Scott L Burrows

SYRE

Scott L Burrows serves as officer: Chief Financial Officer at Spyre Therapeutics, Inc. (SYRE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

10 trades

$2.89M

Net Position

Net Seller

$2.89M

Companies Traded

SYRE, ARQT

Active Period

Dec 2021 – Jun 2026

10 total trades

Most Recent

Sell SYRE

Jun 3, 2026 · $532.9K

Scott L Burrows's Insider Trading at Spyre Therapeutics, Inc. (SYRE)

Buys

0 · $0.00

Sells

5 · $2.62M

Total Shares Bought

Total Shares Sold

64,459

SYRE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 3, 2026	Sell	7,500	$71.06	$532.9K	103,693
May 1, 2026	Sell	12,500	$71.37	$892.1K	97,994
Apr 3, 2026	Sell	7,500	$49.34	$370.1K	99,294
Sep 2, 2025	Sell	18,428	$16.26	$299.6K	0
Sep 5, 2024	Sell	18,531	$28.17	$522.1K	116,422

Scott L Burrows's Insider Trading at Arcutis Biotherapeutics, Inc. (ARQT)

Buys

0 · $0.00

Sells

5 · $275.9K

Total Shares Bought

Total Shares Sold

13,990

ARQT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Mar 6, 2023	Sell	291	$15.26	$4.4K
Feb 28, 2023	Sell	416	$16.17	$6.7K
Mar 3, 2022	Sell	303	$16.85	$5.1K
Mar 1, 2022	Sell	420	$17.75	$7.5K
Dec 27, 2021	Sell	12,560	$20.07	$252.1K